Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GATO
1526
DELISTED
Gatos Silver, Inc.
GATO
| $547K | 0.01% |
133,628
-37,100
| -22% | -$135K |
|
1527
Traeger
COOK
$159M
| $544K | 0.01% |
3,857
-1,419
| -27% | -$237K |
|
1528
Jack in the Box
JACK
$337M
| $544K | 0.01% |
+7,972
| New | +$613K |
|
1529
CALL
Pool Corp
POOL
$6.72B
| $543K | 0.01% |
1,800
-2,900
| -62% | -$919K |
|
1530
PUT
Trinity Industries
TRN
$2.35B
| $543K | 0.01% |
+18,300
| New | +$510K |
|
|
FISV
1531
Fiserv Inc
FISV
$27.9B
| $541K | 0.01% |
+5,349
| New | +$533K |
|
1532
CALL
Altria Group
MO
$113B
| $541K | 0.01% |
+11,800
| New | +$535K |
|
1533
CALL
Avis
CAR
$5.17B
| $539K | 0.01% |
3,300
+400
| +14% | +$80.2K |
|
|
LAND
1534
Gladstone Land Corp
LAND
$374M
| $539K | 0.01% |
29,355
+13,331
| +83% | +$260K |
|
1535
CALL
Agnico Eagle Mines
AEM
$111B
| $536K | 0.01% |
10,300
-8,800
| -46% | -$415K |
|
1536
PUT
Kohl's
KSS
$1.98B
| $536K | 0.01% |
+21,200
| New | +$601K |
|
1537
CALL
Workday
WDAY
$48B
| $536K | 0.01% |
+3,200
| New | +$499K |
|
1538
PUT
Cisco
CSCO
$438B
| $533K | 0.01% |
+11,200
| New | +$510K |
|
1539
CALL
Exelon
EXC
$45.4B
| $533K | 0.01% |
12,300
-5,000
| -29% | -$198K |
|
1540
Fate Therapeutics
FATE
$300M
| $533K | 0.01% |
52,784
+5,785
| +12% | +$109K |
|
1541
CALL
Nutrien
NTR
$34.5B
| $533K | 0.01% |
7,300
-1,400
| -16% | -$111K |
|
1542
Yext
YEXT
$659M
| $532K | 0.01% |
81,439
+12,934
| +19% | +$70.5K |
|
1543
Franklin Templeton
BEN
$17.6B
| $530K | 0.01% |
+20,097
| New | +$499K |
|
1544
CALL
Huntington Ingalls Industries
HII
$11.4B
| $530K | 0.01% |
2,300
+400
| +21% | +$94.2K |
|
1545
CALL
Insulet
PODD
$9.95B
| $530K | 0.01% |
+1,800
| New | +$496K |
|
|
TRUE
1546
DELISTED
TrueCar
TRUE
| $530K | 0.01% |
211,112
-14,555
| -6% | -$30.3K |
|
|
ESPR
1547
DELISTED
Esperion Therapeutics
ESPR
| $529K | 0.01% |
84,949
+13,505
| +19% | +$96.6K |
|
1548
Centene
CNC
$32.3B
| $528K | 0.01% |
6,437
-95,241
| -94% | -$7.78M |
|
1549
CALL
Inspire Medical Systems
INSP
$1.78B
| $528K | 0.01% |
2,100
+400
| +24% | +$85.3K |
|
1550
CALL
H&R Block
HRB
$6.55B
| $526K | 0.01% |
14,400
-17,700
| -55% | -$719K |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.